Evidence map›Paper›PMID 42620793›Full record

ArticleFrontiers in cardiovascular medicine2026

Frailty for cardiovascular risk stratification in CKM syndrome stages 0-3: a UK Biobank prospective cohort study.

Junhong Wang, Ying Zhao, Zongzong Ma

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Junhong WangDepartment of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Ying ZhaoYunnan Provincial Key Laboratory of Public Health and Biosafety & School of Public Health, Kunming Medical University, Kunming, China.
Zongzong MaDepartment of Neurosurgery, Nanshi Hospital of Nanyang, Nanyang, Henan Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Frailty shares common pathophysiological mechanisms with cardiovascular-kidney-metabolic (CKM) syndrome and may contribute to cardiovascular risk. However, evidence regarding the associations of physical frailty and frailty index with cardiovascular outcomes in individuals with CKM stages 0-3 remains limited. Methods: This prospective cohort study included 330,197 participants with CKM stages 0-3 from the UK Biobank. Physical frailty was assessed using a modified Fried frailty phenotype, while frailty index was constructed based on a 49-item deficit accumulation model. Incident cardiovascular disease (CVD), including coronary heart disease (CHD), stroke, heart failure (HF), atrial fibrillation (AF), and peripheral artery disease (PAD), was identified using ICD-10 codes. Associations were evaluated using cause-specific Cox proportional hazards models after adjustment for demographic, socioeconomic, lifestyle, and clinical factors. Restricted cubic spline, subgroup, and sensitivity analyses were further conducted to assess dose-response relationships and the robustness of the findings. Results: Both physical frailty and frailty index were significantly associated with increased risks of CVD and all major cardiovascular subtypes (all Conclusions: Among individuals with CKM stages 0-3, both physical frailty and frailty index were independently associated with increased risks of incident CVD and its major subtypes. Frailty assessment may provide complementary information for cardiovascular risk stratification within the CKM continuum.

Indexed as

cardiovascular diseaseCKM syndromefrailty indexphysical frailtyUK Biobank

Identifiers

PMID42620793
PMCPMC13485804

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.